Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Body Composition Clinical Trials

A listing of Body Composition medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (5) clinical trials

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss Liver Function Body Composition Insulin Resistance Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

The morbidity and mortality from non-alcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, are rapidly increasing as a result of the global explosion in obesity, particularly in the Asia-Pacific region where there will be an estimated 300 million obese people by 20302. Non-alcoholic steatohepatitis (NASH), a subset ...

Phase

Changes in Body Composition After EPA Supplementation in Head and Neck Patients

This study is designed to evaluate the effect of EPA supplementation on muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced (stage III-IVb) to assess that supplementation with EPA can maintain muscle mass along the oncologic treatment. Other aims are to evaluate the nutritional ...

Phase

Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

The purpose of this study is to evaluate the effect of rimonabant, a cannabinoid receptor-1 blocking drug, on the appetite, body weight, body fat and growth hormone level of subjects with Prader-Willi Syndrome (PWS). This will be a double blind placebo controlled clinical trial involving a total of 18 young ...

Phase

PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition

Primary Objectives: 1. To compare CAS and IAS with respect to bone mineral density (BMD): We will determine whether the bone loss associated with long term CAS can be reduced by IAS by evaluation of: 1. BMD, 2. biochemical markers of bone formation/resorption, 3. skeletal relevant events (SRE) (defined as ...

Phase

Liraglutide 3mg (Saxenda) on Weight Body Composition Hormonal and Metabolic Parameters in Obese Women With PCOS

The drug, liraglutide 3.0 mg was approved for chronic weight management in management in obese adults with an initial BMI of 30 kg/m2 or greater or in overweight adults BMI of 27 kg/m2 or greater with at least one weight-related co-morbid condition as an adjunct to a reduced-calorie diet and ...

Phase